The effects of a freeze-thaw cycle and pre-analytical storage temperature on the stability of insulin-like growth factor-I and pro-collagen type III N-terminal propeptide concentrations: Implications for the detection of growth hormone misuse in athletes

Drug Testing and Analysis

Volumn 4, Issue 6, 2012, Pages 455-459

  Guha, Nishan ^a   Erotokritou Mulligan, Ioulietta ^a   Bartlett, Christiaan ^b   Cowan, David A ^b   Bassett, E Eryl ^c   Stow, Michael ^d   Sönksen, Peter H ^a   Holt, Richard I G ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF KENT   (United Kingdom)

^d UK Anti Doping   (United Kingdom)

Author keywords

Doping; GH abuse; IGF I; P III NP; Pre analytical factors

Indexed keywords

ASSAYS; BODY FLUIDS; FREEZING; INSULIN; THAWING;

FREEZE-THAW CYCLES; GROWTH HORMONE-ABUSE; GROWTH HORMONES; INSULIN-LIKE GROWTH FACTOR-I; INTRA-SAMPLE VARIABILITY; N-TERMINAL PROPEPTIDE; PRE-ANALYTICAL FACTOR; PRO-COLLAGEN TYPE III N-TERMINAL PROPEPTIDE; SERUM BIOMARKERS; STORAGE TEMPERATURES;

COLLAGEN;

GROWTH HORMONE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SOMATOMEDIN C;

ACCURACY; ADULT; ARTICLE; ATHLETE; BLOOD SAMPLING; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DRUG MISUSE; FEMALE; FREEZE THAWING; HUMAN; IMMUNOASSAY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUALITY CONTROL; STORAGE; STORAGE TEMPERATURE;

EID: 84863110188     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1339     Document Type: Article

References (15)

1. R. I. Holt, I. Erotokritou-Mulligan, P. H. Sonksen, The history of doping and growth hormone abuse in sport. Growth Horm. IGF Res. 2009, 19, 320.
2. J. K. Powrie, E. E. Bassett, T. Rosen, J. O. Jorgensen, R. Napoli, L. Sacca, et al. Detection of growth hormone abuse in sport. Growth Horm. IGF Res. 2007, 17, 220.
3. R. I. Holt, I. Erotokritou-Mulligan, S. A. Ridley, C. M. McHugh, E. E. Bassett, D. A. Cowan, et al. A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide. Growth Horm. IGF Res. 2009, 19, 43.
4. WADA. The World Anti-Doping Code. International Standard for Laboratories. Available at: [15 July 2008].
5. WADA. Detection of doping with human Growth Hormone. Available at: [20 January 2012].
6. D. A. Cowan, C. Bartlett, Laboratory issues in the implementation of the marker method. Growth Horm. IGF Res. 2009, 19(4), 357.
7. M. L. Healy, R. Dall, J. Gibney, E. Bassett, C. Ehrnborg, C. Pentecost, et al. Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting. J. Clin. Endocrinol. Metab. 2005, 90, 641.
8. N. Guha, I. Erotokritou-Mulligan, C. Burford, G. Strobridge, J. Brigg, T. Drake, et al. Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport. J. Clin. Endocrinol. Metab. 2010, 95, 2969.
9. H. Hartog, W. T. van der Graaf, J. Wesseling, E. van der Veer, H. M. Boezen, Measurement of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 after delayed separation of whole blood samples. Clin. Biochem. 2008, 41, 636.
10. T. G. Harris, H. D. Strickler, H. Yu, M. N. Pollak, E. S. Monrad, M. I. Travin, et al. Specimen processing time andmeasurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3). Growth Horm. IGF Res. 2006, 16, 86.
11. A. R. Kristal, I. B. King, D. Albanes, M. N. Pollak, F. Z. Stanzyk, R. M. Santella, et al. Centralized blood processing for the selenium and vitamin E cancer prevention trial: effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones, and lymphocyte viability. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 727.
12. WADA. World Ant-Doping Program Guidelines for Blood Sample Collection. Available at: [1 June 2011].
13. N. L. Petrakis, Biologic banking in cohort studies, with special reference to blood. Natl. Cancer Inst. Monogr. 1985, 67, 193.
14. N. A. Pinsky, J. M. Huddleston, R. M. Jacobson, P. C. Wollan, G. A. Poland, Effect of multiple freeze-thaw cycles on detection of measles, mumps, and rubella virus antibodies. Clin. Diagn. Lab. Immunol. 2003, 10, 19.
15. I. Erotokritou-Mulligan, E. Eryl Bassett, D. Cowan, C. Bartlett, P. Milward, A. Sartorio, et al. The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score. Clin. Endocrinol. 2009, 72, 520.